-
), the ICGM (JM Campagne, R de Figueiredo) and the IBMM SynBio3 and Peptide team (P.Verdié, G. Subra, C. Echalier). Compounds to be developped will be derived from alterins, a family of antibacterial peptides
Enter an email to receive alerts for coding "https:" "IBMM" positions